EUVIMEDEUVIMED entdecken
Crossref

In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin

Soon Ok Lee, Shinwon Lee iD, Sohee Park, Jeong Eun Lee, Sun Hee Lee

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Soon Ok Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Pusan National University School of Medicine and Medical Research Institute, Pusan National University Hospital, Bus…. Hauptthemen laut MEDLINE: Cefazolin, Anti-Bacterial Agents, Staphylococcus aureus, Pneumonia, Staphylococcal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study compared the efficacy of cefazolin in a mouse pneumonia model caused by a methicillin-susceptible Staphylococcus aureus (MSSA) strain with cefazolin inoculum effect (CIE) and its blaZ-eliminated derivative.

Methods

An isogenic blaZ gene-eliminated strain was derived from type A blaZ-positive MSSA blood isolates exhibiting CIE: PNIDSA230 (parental strain, CIE+) and PNIDSA230c (blaZ-eliminated strain, CIE−). Mice were inoculated with 2 × 10⁶ to 2 × 10⁷ cfu of MSSA via endotracheal tubes and treated with intraperitoneal cefazolin or oxacillin 5 h post-inoculation. Bacterial loads in the lungs (primary sites), liver, and kidneys (metastatic foci) were measured 24 h later.

Results

Cefazolin reduced bacterial densities in the lungs of CIE-positive MSSA-infected mice (n = 11) compared with untreated controls (n = 11) (mean log10 cfu/g ± SD, 6.0 ± 1.6 versus 9.4 ± 2.7; P = 0.006). However, the efficacy of cefazolin was significantly lower in CIE+ infections than in CIE− infections (mean log10 cfu/g ± SD, 6.0 ± 1.6 versus 4.4 ± 0.8, P = 0.0258). Cefazolin-treated CIE− MSSA-infected mice showed no metastatic infections, while 7 of the 11 CIE+ MSSA-infected mice developed liver or kidney infections despite cefazolin treatment. Oxacillin treatment significantly reduced bacterial densities of the lungs, liver, and kidney in CIE-positive (n = 4) and CIE-negative (n = 4) MSSA-infected mice, with no significant differences between CIE-positive and CIE-negative MSSA infections.

Conclusions

CIE may diminish cefazolin’s efficacy in severe MSSA infections and contribute to the development of metastatic infection foci. Oxacillin remains effective regardless of CIE status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefazolinAnti-Bacterial AgentsStaphylococcus aureusPneumonia, StaphylococcalAnimalsMiceLungBacterial LoadKidneyDisease Models, AnimalLiverOxacillinFemaleTreatment Outcome

Substanzen

CefazolinAnti-Bacterial AgentsOxacillin

Autor:innen und Institutionen

  • Department of Internal Medicine, Pusan National University School of Medicine and Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.

ORCID-Profile: Shinwon Lee

Förderung

  • National Research Foundation of Korea
  • Korean government

Zitieren

APA

Lee, S. O., Lee, S., Park, S., Lee, J. E., & Lee, S. H. (2025). In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf065

Vancouver

Lee SO, Lee S, Park S, Lee JE, Lee SH. In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf065

BibTeX
@article{Lee2025,
  author = {Lee, Soon Ok and Lee, Shinwon and Park, Sohee and Lee, Jeong Eun and Lee, Sun Hee},
  title = {In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf065}
}
Kostenlos starten →